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Background: Late preterm infants (34–36  weeks’ gestation) remain a population at 
risk for apnea of prematurity (AOP). As infants affected by respiratory distress syndrome 
(RDS) have immature lungs, they might also have immature control of breathing. Our 
hypothesis is that an association exists between RDS and AOP in late preterm infants.
Objective: The primary objective of this study was to assess the association between 
RDS and AOP in late preterm infants. The secondary objective was to evaluate if an 
association exists between apparent RDS severity and AOP.
Methods: This retrospective observational study was realized in a tertiary care cen-
ter between January 2009 and December 2011. Data from late preterm infants who 
presented an uncomplicated perinatal evolution, excepted for RDS, were reviewed. 
Information related to AOP and RDS was collected using the medical record. Odds 
ratios were calculated using a binary logistic regression adjusted for gestational age 
and sex.
results: Among the 982 included infants, 85 (8.7%) had an RDS diagnosis, 281 (28.6%) 
had AOP diagnosis, and 107 (10.9%) were treated with caffeine for AOP. There was a sig-
nificant association between AOP treated with caffeine and RDS for all infants (OR = 3.3, 
95% CI: 2.0–5.7). There was no association between AOP and RDS in 34 weeks infants 
[AOR: 1.6 (95% CI: 0.7–3.8)], but an association remains for 35 [AOR: 5.7 (95% CI: 
2.5–13.4)] and 36 [OR = 7.8 (95% CI: 3.2–19.4)] weeks infants. No association was 
found between apparent RDS severity and AOP, regarding mean oxygen administration 
duration or complications associated with RDS.
conclusion: The association between RDS and AOP in late preterm infants reflects that 
patients affected by RDS are not only presenting lung immaturity but also respiratory 
control immaturity. Special consideration should be given before discontinuing monitor-
ing after RDS resolution in those patients.
Keywords: apnea, respiratory distress syndrome
Abbreviations: AOP, apnea of prematurity; GA, gestational age; NICU, neonatal intensive care unit; RDS, respiratory distress 
syndrome.
FigUre 1 | exclusion criteria.
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inTrODUcTiOn
Late preterm infants, born between 340/7 and 366/7 weeks gesta-
tional age (GA), account for an important proportion of newborns 
requiring neonatal intensive care, mainly because of respiratory 
morbidity (1–5). As an example, they have a significantly higher 
risk of respiratory distress syndrome (RDS) than term infants 
(RR: 17.3; 95% CI, 9.8–30.6) (4). The incidence of RDS in late 
preterm infants was 15.4% in a study realized by the Canadian 
Neonatal Network (CNN) (6). Late preterm infants affected 
by RDS typically exhibit respiratory distress progressing over 
48–72 h, associated with symptoms, such as tachypnea, nasal flar-
ing, retraction, grunting, and hypoxemia. Apnea of prematurity 
(AOP) is also a more frequent diagnosis in late preterm than in 
term infants, affecting up to 10% of those born at 34 and 35 weeks 
(4, 7, 8). Since AOP is rarely objectified in the first few days of life, 
the diagnosis could easily be omitted with only a short period of 
monitoring (9, 10). Late preterm infants are also recognized to 
be at higher risk of unfavorable neurodevelopmental outcomes 
when compared with term infants (11–15). Developmental 
impacts of AOP are not well-known, and a causal relationship is 
not clearly established. However, some data raise great concerns 
about untreated AOP and neurodevelopmental impairments 
(16–19). As a consequence, pediatricians are daily confronted 
with monitoring issues and safe discharge concerning those 
infants. As AOP is a manifestation of immaturity, it might be 
worthwhile to pay attention to other immaturity manifestations, 
as they may be associated with AOP. This would help target more 
precisely which patient needs monitoring. We postulate that as 
late preterm infants affected by RDS have immature lungs, they 
may also have immature control of breathing and are at higher 
risk of AOP. Therefore, we hypothesized that RDS will be associ-
ated with AOP in late preterm infants. The primary objective of 
this study was to assess the association between RDS and AOP in 
a late preterm population. The secondary objective was to evalu-
ate the association between apparent RDS severity and AOP in 
the population of late preterms affected by RDS.
MaTerials anD MeThODs
study Design and Population
This is a tertiary care center, retrospective cohort study of the 
population of late preterm infants admitted between January 2009 
and December 2011. Participants were identified through medi-
cal records review. The studied population included late preterm 
infants born or admitted to the Mother and Child Center of the 
CHU de Québec and who presented an uncomplicated perinatal 
evolution, except for RDS. We included only patients susceptible 
to be discharged soon after birth or after RDS resolution. The 
list of every diagnosis from the medical records was reviewed 
for each patient by the main author. Those who presented any 
medical or surgical condition that could significantly prolong the 
need for cardiorespiratory monitoring were excluded according 
to pre-specified criteria (Figure 1). The included patients were 
hospitalized either in the neonatal intensive care unit (NICU), in 
the newborn nursery, or in the moms’ room. Frequent reasons for 
NICU admission at birth included respiratory distress and birth 
weight under 2.3 kg as per our protocol. All the patients admitted 
to the NICU received systematic cardiorespiratory monitoring. 
Those requiring intravenous infusion were hospitalized in the 
newborn nursery. This study was approved by the hospital ethics 
committee. Since this is a retrospective study and that all infor-
mation collected were anonymous, no consent was required.
Variables and Data sources
The primary outcomes of this study were AOP, and AOP treated 
with caffeine (caffeine citrate). Patients were reported having 
TaBle 1 | study population.
Patients included in the study 
(N = 982)
Patients with rDs 
(N = 85)
Patients with no rDs 
(N = 897)
Mean birth weight, grams (sD) 2523 (386) 2504 (435)
ga, N (%)
340/7 to 366/7 85 (100%) 897 (100%)
340/7 to 346/7 35 (41.1%) 191 (21.3%)
350/7 to 356/7 27 (31.8%) 244 (27.2%)
360/7 to 366/7 23 (27.1%) 462 (51.5%)
Males, N (%)
340/7 to 366/7 52/85 (61.2%) 465/897 (51.9%)
340/7 to 346/7 16/35 (45.7%) 106/191 (55.2%)
350/7 to 356/7 18/27 (66.7%) 123/244 (50.6%)
360/7 to 366/7 18/23 (78.3%) 236/462 (51.2%)
aOP, N (%)
340/7 to 366/7 54/85 (63.5%) 227/897 (25.3%)
340/7 to 346/7 27/35 (77.1%) 129/191 (67.5%)
350/7 to 356/7 18/27 (66.7%) 63/244 (25.8%)
360/7 to 366/7 9/23 (39.1%) 35/462 (7.6%)
caffeine, N (%)
340/7 to 366/7 22/85 (25.9%) 85/897 (9.5%)
340/7 to 346/7 15/34 (42.9%) 50/191 (26.2%)
350/7 to 356/7 4/27 (14.8%) 26/244 (10.7%)
360/7 to 366/7 3/23 (13.0%) 9/462 (1.9%)
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AOP and/or RDS diagnosis if these diagnoses were reported 
on the medical discharge summary. The diagnosis of AOP and 
RDS was confirmed on discharge summary by the attending 
physician who sent the patient home. To be classified as hav-
ing a RDS, the patient must have required respiratory support 
and being hospitalized in the NICU. In the institution, AOP is 
defined by one of these three situations: the absence of breathing 
movements for 15  s or more, an abnormal respiratory pattern 
(bradypnea or superficial respiration) associated with oxygen 
saturation below 85%, or bradycardia below 100 beats per minute 
(20). Distinction between central, obstructive, or mixed apnea 
was not possible. Caffeine treatment was documented according 
to the hospital’s pharmacy database. Caffeine administration was 
based on clinical decision of the attending physician, according 
to frequency or severity of AOP, without pre-established criteria. 
GA and sex were considered as potential confounding factors for 
the main outcomes and were obtained from the medical records. 
Information from medical records and from pharmacy databases 
was merged according to chart numbers.
Secondary outcomes were only assessed in patients affected 
by RDS whether they presented AOP and/or received caffeine 
treatment or not. They included the duration of oxygen admin-
istration, ventilation support, and NICU hospitalization, as well 
as the combined outcome of mechanical ventilation exposure 
and pneumothorax. Ventilatory support included mechanical 
ventilation, non-invasive respiratory support/ventilation (nasal 
continuous positive pressure ventilation, nasal intermittent 
positive pressure ventilation, and sight positive airway pressure), 
and high flow nasal cannula. The charts of patients with RDS 
diagnosis have been reviewed to collect the data related to the 
secondary outcomes.
Bias
As AOP diagnosis were made clinically, without diagnostic evalu-
ation for most of the patients, the outcome of AOP treated with 
caffeine was used as a proxy for infants with more significant 
AOP. This strategy was used in order not to overestimate the 
association between RDS and AOP.
statistical Methods
Descriptive statistics are presented using percentages and 
means with SD. Adjusted analysis for sex and GA is presented 
using mean and SE. The primary outcomes were tested using a 
binary logistic regression model to obtain odds ratio. The simple 
effects between sex, GA, and RDS on AOP were assessed, and 
interaction was tested when necessary. Secondary outcomes were 
analyzed using an ANOVA, estimated with a linear mixed model 
for heterogeneous variances, to see the effects of caffeine or apnea, 
and adjusted for GA and sex. Bonferroni multiplicity correction 
was used when needed. All statistical analyses were performed 
with SAS, version 9.3 (SAS Institute Inc., Cary, NC, USA).
resUlTs
During the study period, 1101 late preterm infants were admit-
ted to the Mother and Child Center of the CHU de Québec and 
119 (10.8%) were excluded according to the exclusion criteria 
(Appendix A). Among all excluded patients, there were 35, 40, 
and 44 patients, respectively, aged from 34 to 36  weeks GA. 
Twenty (16.8%) of them had a RDS diagnosis, and 37 (31.1%) 
had an AOP diagnosis. Fifteen (12.6%) had both AOP and RDS 
diagnosis.
Among the 982 patients forming the studied group, 85 (8.7%) 
had a RDS diagnosis, 281 (28.6%) had an AOP diagnosis, and 107 
(10.9%) were treated with caffeine for AOP. Patients with RDS 
diagnosis were all admitted to the NICU and required respiratory 
support. Among the 897 patients not affected by RDS, 65% were 
admitted in the NICU.
Distribution according to GA and sex and descriptive data for 
the primary outcomes are presented in Table 1. The proportion 
of males increased from 34 to 36 weeks in the RDS group, but it 
remained stable in patients without RDS (Table 1). In the group 
of patients with RDS, 21 were exposed to mechanical ventilation 
and also received surfactant and 11 presented a pneumothorax.
Primary Outcomes
Apnea of Prematurity
There was a significant interaction between RDS and GA for 
the AOP outcome (p = 0.015). Therefore, AOP odds ratio were 
stratified by GA, and there was no more association between 
RDS and AOP in 34 weeks infants (OR = 1.6, 95% CI: 0.7–3.7). 
Nonetheless, a significant association remains for 35 (OR = 6.2, 
95% CI: 2.6–14.6) and 36 (OR = 8.8, 95% CI: 3.5–22.0) weeks 
infants. The overall AOP rate was 30.0% in females and 27.1% 
in males. Therefore, being a male was slightly associated with a 
decreased risk of AOP (OR = 0.69, 95% CI: 0.49–0.97) according 
to the logistic regression model. There was no interaction between 
GA and sex (p = 0.33) neither between RDS and sex (p = 0.27) 
for the AOP outcome.
TaBle 3 | secondary outcomes summary for patients with rDs 
regarding aOP treated with caffeine.
caffeine for aOP,  
Yes (22)/no (63)
adjusted meana (se) anOVa  
p-value
anOVa 
p-value
Oxygen duration (days) 1.5 (1.4)/2.5 (1.9) 1.8 (0.4)/2.6 (0.2) 0.08
Ventilation (days) 5.4 (3.6)/4.6 (2.4) 5.4 (0.5)/4.6 (0.3) 0.2
Hospitalization (days) 14.9 (10.6)/9.7 (4.7) 14.6 (2.4)/9.8 (0.6) 0.05
aNo interaction where significant for GA and sex and therefore the model used does 
not consider it.
TaBle 2 | secondary outcomes summary for patients with rDs 
regarding aOP.
aOP, Yes  
(54)/no (31)
Unadjusted meana 
(sD)
adjusted meana 
(se)
anOVa  
p-value
Oxygen duration (days) 2.3 (1.7)/2.1 (2.0) 2.5 (0.2)/2.1 (0.3) 0.3
Ventilation (days) 5.4 (3.0)/3.7 (1.9) 5.2 (0.3)/4.0 (0.4) 0.02
Hospitalization (days) 12.5 (8.2)/8.4 (3.3) 12.3 (1.1)/8.9 (0.7) 0.01
aNo interaction where significant for GA and sex and therefore the model used does 
not consider it.
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AOP Treated with Caffeine
Both GA (OR = 3.13, 95% CI 1.94–5.06, p < 0.0001) and RDS 
(OR =  2.24, 95% CI 1.26–3.97, p =  0.0059) were individually 
associated with caffeine exposure according to the logistic regres-
sion model. There was no interaction between GA and RDS for 
that issue (p = 0.13). RDS was associated with AOP treated with 
caffeine (OR = 3.3, 95% CI: 2.0–5.7). There was no interaction 
between GA and sex (p =  0.97) neither between RDS and sex 
(p = 0.66) for the outcome of being treated with caffeine for AOP.
secondary Outcomes
Results of the secondary outcomes for the 85 patients affected by 
RDS are summarized in Table 2 and Table 3.
Oxygen
Mean oxygen duration for RDS was 2.3 (SD: 1.8) days for all 
patients. No significant relation was found between oxygen dura-
tion for RDS and AOP or caffeine administration for AOP.
Ventilatory Support
Mean ventilation support duration was 4.8 (SD: 2.8) days for 
all patients. Apnea diagnosis was associated with prolonged 
ventilation support, but this difference was not significant when 
addressing patients treated with caffeine.
NICU Hospitalization
Mean hospitalization duration in the NICU was 11.4 (SD: 7.1) 
days for all patients, and it was significantly longer in patients 
who presented AOP. The same association was observed for 
patients treated with caffeine, but the difference was borderline 
significant.
RDS Complications
No association was found in the regression model between 
AOP and the composite outcome of pneumothorax and/or 
invasive ventilation exposure (OR =  0.35, 95% CI: 0.12–1.03, 
p =  0.06). This composite outcome was nonetheless associated 
with prolonged oxygen duration (3.1 vs. 2.1 days, p = 0.02), but 
no association was found with ventilation support duration (4.6 
vs. 5.1 days, p = 0.34) neither hospitalization duration (10.8 vs. 
11.6 days, p = 0.61).
DiscUssiOn
This study supports that late preterm infants suffering of RDS 
are at higher risk of AOP. Therefore, it confirms our research 
hypothesis regarding the association between respiratory mani-
festations of immaturity and AOP in late preterm infants. RDS 
was associated with AOP in 35 and 36 weeks infants, which are 
normally expected to show a higher level of respiratory control 
maturity, but not in 34 weeks infants. It is possible that patients of 
34 weeks had a similar AOP rate in both groups because they have 
been more systematically monitored, even those without RDS. 
However, the association between AOP treated with caffeine and 
RDS was significant for all infants without interaction with GA. 
In fact, this association reflects the link between RDS and more 
significant AOP.
In 2011, Eichenwald et al. published a study addressing AOP 
very similar to our regarding inclusion criteria and data sources, 
but targeting 33 and 34  weeks’ infants instead of late preterm 
(21). Therefore, the AOP incidence reported in their study (49%) 
was superior to the one found in our study (29%). Interestingly, 
they found a similar relation between AOP and length of hospital 
stay (21). In our study, there was no association either between 
duration of oxygen supplementation or RDS complications and 
the occurrence of AOP. This suggests that there is no relation 
between the severity of RDS and AOP. Nonetheless, we observed 
a significant interaction between duration of ventilation support 
and AOP in the RDS group. As there is no relation between oxy-
gen supplementation and AOP, we hypothesized that the longer 
maintenance of ventilation support in that group was related to 
AOP rather than RDS.
Different mechanisms may contribute to the association 
between RDS and AOP in the population of late preterm infants. 
First, important changes in the dynamic of lung compliance 
occur until 38  weeks, contributing to the stabilization of the 
residual functional capacity (1, 22). The decreased in the residual 
functional capacity observed in RDS increase the susceptibility 
to more frequent and prolonged desaturations (1). Furthermore, 
RDS is thought to affect autonomic control in late preterm 
infants since it is associated with long-term decrease in heart rate 
variability, a pattern usually observed in more preterm infants. 
The mechanism explaining this autonomic variation needs to be 
better understand, but it may be related to RDS itself and could 
account for persistent AOP (8, 23). Otherwise, it is known that 
late preterm infants have an immature respiratory response to 
hypoxia and to hyperoxia (22, 24). Dysregulation of peripheral 
chemoreceptors sensitivity, due to early postnatal hypoxemia, 
may be involved in the increase susceptibility to AOP in infants 
affected by RDS (24). Furthermore, chemoreceptors effectiveness 
remains dependent to the response of central mechanisms vary-
ing with the degree of brain maturation, which is not completed 
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in late preterm infants (24). Additionally, the decline in ventila-
tory response associated with hyperoxia is known to increase 
the frequency of AOP, especially in those that exhibit periodic 
breathing, a frequent respiratory pattern present in late preterm 
infants (22, 25). This could have been an issue in patients exposed 
to prolonged oxygen administration for RDS, beyond the first 
days of life.
Clinicians’ concerns about AOP are mainly related to hypoxic 
episodes and their impact on long-term neurological develop-
ment. Although they are not clearly supported by the literature, 
potential life threatening events are also worrisome. It is known 
that late preterm infants are at higher risk of unfavorable neu-
rodevelopmental outcomes when compared with term infants 
(11–15). Even though the causal relation between AOP and poor 
neurodevelopmental outcome is not clearly established, some data 
raise great concerns about this issue, mainly in extremely preterm 
infants (16, 17, 19, 26, 27). Therefore, the optimal duration of 
cardiorespiratory monitoring in accordance with the natural 
evolution of AOP is unknown. Nonetheless, it is suggested that 
the first days of life are not the best window to proceed to a res-
piratory control diagnostic study (respirogram or pulse oximeter 
recording) (9). In our center, no infant is submitted to such an 
evaluation before 7 days of life and usually not before 39 weeks 
corrected age. Once an infant present AOP, he will remain on 
monitoring for up to 7 days after its last spell. Because cardiores-
piratory monitoring is not mandatory, it may be discontinued 
shortly after RDS resolution if no AOP is documented during the 
initial monitoring. Evaluation is only requested for infants who 
present clinical manifestations of apnea, and no monitoring of the 
saturation in the car seat is performed in our institution before 
discharge as per new recommendations in Canada (28, 29).
Although our study included a large number of late preterm 
infants, we must acknowledge some of its limitations. On the one 
hand, the diagnosis of AOP was made clinically, and this may 
have underestimated the real incidence of AOP, mainly in 35 
and 36 weeks infants without RDS. These patients were probably 
less likely to be monitored, while patients affected by RDS were 
systematically monitored. If this hypothesis is exact, it may have 
resulted in an increased likelihood of the association between 
AOP and RDS. On the other hand, we may have overestimated 
the global rate of AOP because of the diagnosis criteria used in 
our center. Indeed, AOP diagnostic criteria remained variable 
between institutions as the cut off for bradycardia may vary from 
80 to 100. Eichenwald et al. (21) reported this issue in their study 
pointing out the subjectivity of the diagnosis and the accuracy of 
data about AOP. They reported a rate of AOP diagnosis ranging 
from 24 to 76% among 10 sites. In our study, the 100 cut off point 
for bradycardia made the diagnosis more likely and therefore we 
may have overestimated the rates of AOP. Nonetheless, the same 
diagnosis criteria were used for all infants, and it should not have 
impacted the association between RDS and AOP. Furthermore, 
using the odds ratio for caffeine treatment allows to get a more 
significant picture from a clinical standpoint as patients treated 
with caffeine certainly presented more important manifestations 
of AOP either in severity or frequency. In rare cases, patients 
may have received caffeine before being discharged with home 
monitoring for periodic breathing, and this study did not allow 
us to identify those patients. However, periodic breathing is a 
pattern of alternating breaths and brief respiratory pauses and is 
considered as a marker of AOP (30).
cOnclUsiOn
Our study supports that RDS, a manifestation of pulmonary 
immaturity, is a marker for higher susceptibility of respiratory 
control immaturity in late preterm infants since it is associated 
with AOP. Therefore, special consideration should be given before 
discontinuing monitoring after RDS resolution. A prospective 
study addressing respiratory control would be an important step 
toward achieving clarity on the issue of AOP in late preterm 
infants. It could also allow to determine the best window and the 
appropriate duration for cardiorespiratory monitoring.
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a. 119 excluded patients per categories
 1. Congenital heart disease with hemodynamic or respiratory 
impact including patent ductus arteriosus requiring medical 
treatment with Ibuprofen
 ◦ 7 patients
 2. Congenital disease of the airway and lungs and airway 
obstruction
 ◦ 6 patients
 3. Chromosomal anomaly and genetic disease
 ◦ 11 patients
 4. Congenital malformation
 ◦ 26 patients
 5. Neuromuscular disorder including idiopathic or transient 
hypotonia of the newborn
 ◦ 6 patients
 6. Early onset sepsis with positive blood, cerebrospinal fluid, or 
urine culture
 ◦ 7 patients
 7. Any condition that required surgery before discharge after 
birth
 ◦ 16 patients
 8. Other medical conditions susceptible to prolong the hospitali-
zation course (e.g., pneumonia, PPHN, necrotizing enterocol-
itis, seizures, hypoxic ischemic encephalopathy, IVH, multiple 
organ failure, and hydrops)
 ◦ 39 patients
 9. Death before discharge
 ◦ 1 patient
